<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B406901C-18C6-4056-A84C-156812C93DFF"><gtr:id>B406901C-18C6-4056-A84C-156812C93DFF</gtr:id><gtr:name>Solexa</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598"><gtr:id>798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598</gtr:id><gtr:name>Agilent Technologies UK Ltd</gtr:name><gtr:address><gtr:line1>610 Wharfedale Road</gtr:line1><gtr:line2>IQ Winnersh</gtr:line2><gtr:postCode>RG41 5TP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E44802B3-B0D4-4621-BD90-3DC456BFD227"><gtr:id>E44802B3-B0D4-4621-BD90-3DC456BFD227</gtr:id><gtr:name>Human Genetic Signatures</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7233F24-93D3-40B6-A4C4-54222647E41F"><gtr:id>F7233F24-93D3-40B6-A4C4-54222647E41F</gtr:id><gtr:name>University of Bonn</gtr:name><gtr:address><gtr:line1>Katzenburgweg 5</gtr:line1><gtr:line4>Bonn</gtr:line4><gtr:line5>D-53115</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0625E546-D921-4916-A4C8-3F14CD3EC72B"><gtr:id>0625E546-D921-4916-A4C8-3F14CD3EC72B</gtr:id><gtr:name>New England Biolabs</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0517AC0E-EF12-4F19-A6DD-6406FF2123A2"><gtr:id>0517AC0E-EF12-4F19-A6DD-6406FF2123A2</gtr:id><gtr:name>Life Technologies</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E9AC2A04-B282-4238-BB69-10630073CC70"><gtr:id>E9AC2A04-B282-4238-BB69-10630073CC70</gtr:id><gtr:name>Domantis Ltd</gtr:name><gtr:address><gtr:line1>315 Cambridge Sciences Park</gtr:line1><gtr:postCode>CB4 0WG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4"><gtr:id>1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4</gtr:id><gtr:name>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7139BFEB-6864-440A-B3D7-96AE398AA5B1"><gtr:id>7139BFEB-6864-440A-B3D7-96AE398AA5B1</gtr:id><gtr:name>University of Konstanz</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88B1E177-B3F4-421A-85E1-683228DE3D70"><gtr:id>88B1E177-B3F4-421A-85E1-683228DE3D70</gtr:id><gtr:name>Arizona State University</gtr:name><gtr:address><gtr:line1>PO Box 875603</gtr:line1><gtr:line2>1120 S Cady Mall</gtr:line2><gtr:line3>INDTDSB 366</gtr:line3><gtr:line4>Tempe</gtr:line4><gtr:line5>AZ</gtr:line5><gtr:postCode>85282</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E609EBA3-2647-421C-931F-D9605AE807FA"><gtr:id>E609EBA3-2647-421C-931F-D9605AE807FA</gtr:id><gtr:name>University of Notre Dame</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31C37D4D-86D3-4E73-B4EB-2AAE728434C1"><gtr:id>31C37D4D-86D3-4E73-B4EB-2AAE728434C1</gtr:id><gtr:name>Exiqon</gtr:name><gtr:address><gtr:line1>Skelstedet 16</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9292BA12-F8E2-4EAC-9C81-4F0CE7D6E16E"><gtr:id>9292BA12-F8E2-4EAC-9C81-4F0CE7D6E16E</gtr:id><gtr:name>Helicos Biosciences</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B406901C-18C6-4056-A84C-156812C93DFF"><gtr:id>B406901C-18C6-4056-A84C-156812C93DFF</gtr:id><gtr:name>Solexa</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598"><gtr:id>798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598</gtr:id><gtr:name>Agilent Technologies UK Ltd</gtr:name><gtr:address><gtr:line1>610 Wharfedale Road</gtr:line1><gtr:line2>IQ Winnersh</gtr:line2><gtr:postCode>RG41 5TP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E44802B3-B0D4-4621-BD90-3DC456BFD227"><gtr:id>E44802B3-B0D4-4621-BD90-3DC456BFD227</gtr:id><gtr:name>Human Genetic Signatures</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7233F24-93D3-40B6-A4C4-54222647E41F"><gtr:id>F7233F24-93D3-40B6-A4C4-54222647E41F</gtr:id><gtr:name>University of Bonn</gtr:name><gtr:address><gtr:line1>Katzenburgweg 5</gtr:line1><gtr:line4>Bonn</gtr:line4><gtr:line5>D-53115</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0625E546-D921-4916-A4C8-3F14CD3EC72B"><gtr:id>0625E546-D921-4916-A4C8-3F14CD3EC72B</gtr:id><gtr:name>New England Biolabs</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0517AC0E-EF12-4F19-A6DD-6406FF2123A2"><gtr:id>0517AC0E-EF12-4F19-A6DD-6406FF2123A2</gtr:id><gtr:name>Life Technologies</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E9AC2A04-B282-4238-BB69-10630073CC70"><gtr:id>E9AC2A04-B282-4238-BB69-10630073CC70</gtr:id><gtr:name>Domantis Ltd</gtr:name><gtr:address><gtr:line1>315 Cambridge Sciences Park</gtr:line1><gtr:postCode>CB4 0WG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4"><gtr:id>1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4</gtr:id><gtr:name>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7139BFEB-6864-440A-B3D7-96AE398AA5B1"><gtr:id>7139BFEB-6864-440A-B3D7-96AE398AA5B1</gtr:id><gtr:name>University of Konstanz</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88B1E177-B3F4-421A-85E1-683228DE3D70"><gtr:id>88B1E177-B3F4-421A-85E1-683228DE3D70</gtr:id><gtr:name>Arizona State University</gtr:name><gtr:address><gtr:line1>PO Box 875603</gtr:line1><gtr:line2>1120 S Cady Mall</gtr:line2><gtr:line3>INDTDSB 366</gtr:line3><gtr:line4>Tempe</gtr:line4><gtr:line5>AZ</gtr:line5><gtr:postCode>85282</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E609EBA3-2647-421C-931F-D9605AE807FA"><gtr:id>E609EBA3-2647-421C-931F-D9605AE807FA</gtr:id><gtr:name>University of Notre Dame</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31C37D4D-86D3-4E73-B4EB-2AAE728434C1"><gtr:id>31C37D4D-86D3-4E73-B4EB-2AAE728434C1</gtr:id><gtr:name>Exiqon</gtr:name><gtr:address><gtr:line1>Skelstedet 16</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9292BA12-F8E2-4EAC-9C81-4F0CE7D6E16E"><gtr:id>9292BA12-F8E2-4EAC-9C81-4F0CE7D6E16E</gtr:id><gtr:name>Helicos Biosciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4E0C9AEB-6477-44A5-8168-1E018DDF528C"><gtr:id>4E0C9AEB-6477-44A5-8168-1E018DDF528C</gtr:id><gtr:firstName>Philipp</gtr:firstName><gtr:surname>Holliger</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105178804"><gtr:id>CB941B26-7677-4EA4-B8AF-59A482FCBD70</gtr:id><gtr:title>Evolution of Novel Biopolymers</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105178804</gtr:grantReference><gtr:abstractText>Every organism?s blueprint is stored as genetic information encoded in DNA. Before a cell can divide, its genetic information needs to be copied and duplicated. This process is carried out by sophisticated enzymes called polymerases. The astonishing ability of polymerases to both ?read? and ?write? genetic information is vital to all life on earth and central to modern biology and medicine enabling genome sequencing and the polymerase chain reaction. Our work is aimed at the engineering of novel polymerases capable of activity in unfavourable conditions, and utilising unnatural building blocks. Such &amp;quot;designer&amp;quot; polymerases will be key enabling technologies for the generation of next-generation nucleic acid drugs, sensors and nanomaterials.</gtr:abstractText><gtr:technicalSummary>Synthetic biology seeks to probe fundamental aspects of biological form and function by construction (i.e. resynthesis) rather than deconstruction (analysis). Synthesis thus complements reductionist and analytic studies of life, and allows novel approaches towards fundamental biological questions. 

We have been exploiting the synthesis paradigm to explore the chemical etiology of the genetic apparatus shared by all life on earth. Specifically, we ask why information storage and propagation in biological systems is based on just two types of nucleic acids, DNA and RNA. Is the chemistry of life?s genetic system based on chance or necessity? Does it reflect a &amp;quot;frozen accident&amp;quot;, imposed at the origin of life, or are DNA and RNA functionally superior to simple alternatives.

We have developed advanced generation selection strategies, that allow the evolution of polymerases capable of utilizing exclusively unnatural nucleotide substrates enabling the enzymatic synthesis, replication and evolution of entirely synthetic genetic polymers (XNA). Such systems expand the central dogma and will conclusively address questions such as the capacity of genetic polymers other than DNA and RNA for information storage and propagation (i.e. heredity). Beyond heredity, we have demonstrated a capacity for Darwinian evolution by the de novo selection of specific ligands (XNA aptamers) and catalysts (XNAzymes) based on these entirely synthetic backbones. Thus, key hallmarks of living systems, including heredity and evolution are not limited to DNA and RNA but can be implemented in synthetic polymers and are likely to be emergent properties of polymers capable of information storage. 

The further exploration of the informational, structural and catalytic potential of synthetic genetic polymers, should advance our understanding of the parameters of chemical information encoding, and will provide a source of novel ligands, catalysts and nanostructures with tailor-made chemistries for applications in biotechnology and medicine. 

We have also leveraged our selection technology to make progress in the engineering and evolution of RNA polymerase ribozymes towards a general polymerase and self-replication capacity We have discovered RNA polymerase ribozymes that are capable of the templated synthesis (i.e. transcription) of another simple ribozyme or RNA oligomers exceeding their own size (&amp;gt;200 nts), a key milestone on the road to self-replication.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>8548148</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>DNA/XNA origami nanopores</gtr:description><gtr:id>C843CBFA-E5C6-4A4C-ABDD-8757594442A5</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e048e05d8666.91339506-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern Denmark</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>LNA and UNA triphosphates as polymerase substrates</gtr:description><gtr:id>BABA5C78-E59B-44F1-80A7-7063A7998887</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e04a61174dc4.11181618-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helicos Biosciences</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mutant Polymerases</gtr:description><gtr:id>A19AF521-AB47-4F83-B3DA-9BB0614E831C</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-5</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agilent Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Oligonucleotide arrays</gtr:description><gtr:id>54AEEBC2-7D9E-4801-B9DE-1E6BE9023BE5</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e040de694386.26071657-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stanford University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Hydrophobic base analogues</gtr:description><gtr:id>8A125BE9-4F99-41D5-BF3C-F76BBA5AC783</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e04912e08ce6.98550878-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Notre Dame</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Chemistry and Biochemistry</gtr:department><gtr:description>SHAPE mapping of XNAs and RNAs</gtr:description><gtr:id>E5427C13-C497-44ED-ADDE-9E355BD7BE59</gtr:id><gtr:impact>publication: 25470036 (February, 2015) Catalysts from synthetic genetic polymers.</gtr:impact><gtr:outcomeId>56e04a1bcfdfe1.44481860-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Translesion synthesis of XNA polymerases</gtr:description><gtr:id>783452DF-EE68-461A-99D5-7982B9B44563</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e04a93a1e9c6.47116056-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bonn</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>XNA side-chain modification chemistry</gtr:description><gtr:id>C7CD291C-381F-4266-94CF-97AB747D8B85</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e0494ba582a5.32976981-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agilent Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mutant Polymerases</gtr:description><gtr:id>8FCA6540-944D-4141-9BF8-5155F3E3F2EE</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-4</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry</gtr:department><gtr:description>CyDNA in super-resolution microscopy</gtr:description><gtr:id>CA3541A1-75E9-4DA7-84FE-BA91AEC3BA1E</gtr:id><gtr:impact>publication: 22861666 (August, 2012) Reversible Fluorescence Photoswitching in DNA.</gtr:impact><gtr:outcomeId>56e045014672e0.71756143-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Life Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Invitrogen</gtr:department><gtr:description>Mutant Polymerases</gtr:description><gtr:id>DE467B95-B79D-4707-BAC3-9CAFC273CA8E</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-1</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Solexa</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mutant Polymerases</gtr:description><gtr:id>3BE2C6B0-63C0-4FE8-95C2-55400E0D9DF3</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-3</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Exiqon</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Mutant Polymerases</gtr:description><gtr:id>7B058F5C-E345-4C12-A473-6EB6AFF886CF</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-6</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Human Genetic Signatures</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Polymerases for Bisulfite Sequencing</gtr:description><gtr:id>E1C8B4DB-4468-432A-9C1F-E9AC3D101F1F</gtr:id><gtr:impact>evaluation agreement</gtr:impact><gtr:outcomeId>9761E32B73E-1</gtr:outcomeId><gtr:partnerContribution>evaluation agreement</gtr:partnerContribution><gtr:piContribution>evaluation agreement</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>CryoEM imaging of XNA nanotechnology objects</gtr:description><gtr:id>853AD374-4769-4602-8D07-E7721D199EC9</gtr:id><gtr:impact>first structures of XNA nano-object</gtr:impact><gtr:outcomeId>56e040af4eac20.26714096-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Domantis Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Polymerase Evolution</gtr:description><gtr:id>ED00005B-2ADF-40DF-B433-2EF0F4E47903</gtr:id><gtr:impact>funding of postdoctoral researchers, cost of patent prosecution, consumables; Collaboration agreement with Domantis funded 2 postdoctoral scientists in my group</gtr:impact><gtr:outcomeId>9954E6F7F26-1</gtr:outcomeId><gtr:partnerContribution>Collaboration agreement with Domantis funded 2 postdoctoral scientists in my group</gtr:partnerContribution><gtr:piContribution>development of novel directed evolution methodologies for proteins and in particular polymerases</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Arizona State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Molecular Sciences</gtr:department><gtr:description>TNA triphosphates as polymerase substrates.</gtr:description><gtr:id>6665409D-461A-4CBC-A795-21F5948FA374</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e044b93d2a00.25251113-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ETH Zurich</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Deep Screening</gtr:description><gtr:id>B19E8121-F264-4BBD-B551-E19F76B95754</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e049e8405346.87240888-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>In vivo target discovery</gtr:description><gtr:id>BE684484-D1CD-4AF3-9209-54AE604024C2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e041157fd751.89392502-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>X-ray crystallography of mutant DNA polymerases.</gtr:description><gtr:id>C00EE1B6-34DD-451F-8BBB-941DBBDCAC57</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>56e0407c224013.73681076-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Konstanz</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Structural studies of XNA polymerases.</gtr:description><gtr:id>F9A84651-C3EA-41BA-B3E4-365E8F269036</gtr:id><gtr:impact>23940661 (, 2013) Structures of an apo and a binary complex of an evolved archeal B family DN...</gtr:impact><gtr:outcomeId>56e04979f40190.02268314-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Life Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Applied Biosystems</gtr:department><gtr:description>Mutant Polymerases</gtr:description><gtr:id>E193CD64-D9BB-42BB-B775-BAD0B39BD40C</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-7</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>New England Biolabs</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mutant Polymerases</gtr:description><gtr:id>9D174A38-F336-4622-9047-7D9E316A8EE3</gtr:id><gtr:impact>generation of licensing revenue for MRC</gtr:impact><gtr:outcomeId>07B2F9EAE40-2</gtr:outcomeId><gtr:partnerContribution>non-exclusive license for both polymerases and CSR selection technology potential for collaboration</gtr:partnerContribution><gtr:piContribution>generation of novel polymerases with potential biotechnological impact</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Phage Display</gtr:description><gtr:id>BC37982A-606A-4ED3-87D1-87ED0564935D</gtr:id><gtr:impact>contribution to settlement</gtr:impact><gtr:outcomeId>5B755F30B85-1</gtr:outcomeId><gtr:partnerContribution>GSK/ Domantis dispute with AbLynx</gtr:partnerContribution><gtr:piContribution>consulting for GSK/ Domantis dispute with AbLynx</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Society talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7E06EBA6-7013-4060-996E-BD24133199CE</gtr:id><gtr:impact>Gave talk at Cambridge Scientific Society with more than 1000 permanent members (and a much larger email database). The Society is a prestigious platform for the first public exposure of new research and findings. Past speakers include Nobel Laureates James Watson, Sir Tim Hunt and Sir John Walker, eminent scientists Sir Roger Penrose, Sir Richard Friend, Sir John Beddington and Peter Atkins, popular author Matt Ridley, and former Universities and Sciences minister David Willetts among many others.

Tlk was well received by ca. 100 attendees and prompted many discussions and online Tweets.</gtr:impact><gtr:outcomeId>56e05e38892a44.78375221</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.scisoc.com/talks/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30B6CBA5-04FC-46E9-83AB-436376D4F898</gtr:id><gtr:impact>phone interview for Guardian article &amp;quot;Biologists join the race to create synthetic life&amp;quot;

article</gtr:impact><gtr:outcomeId>5F70466A2C7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC4 radio program</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2017F3BB-47AC-4580-8113-4059C3A4946C</gtr:id><gtr:impact>Radio science program

NA</gtr:impact><gtr:outcomeId>g6KuHwr83se</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk for non-scientific staff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8A193193-F2F6-4671-A73B-8F0697ABFE16</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

better understanding of my research by support staff</gtr:impact><gtr:outcomeId>5460ab82f0ab63.52029374</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RSC Policy seminar</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>86364C24-AC54-461F-8B8C-D46ACAA881C5</gtr:id><gtr:impact>seminar to public / policymakers about impact and future of synthetic biology

interviews with journalists e.g. Today program, Guardian science podcast etc.</gtr:impact><gtr:outcomeId>F4A4142E34B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Orthosome</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>066CD588-D634-4DA3-89D4-831CA4766E15</gtr:id><gtr:impact>describe FP6 funded project : orthosome on website

feedback on project, attract students</gtr:impact><gtr:outcomeId>44C96B2D052</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RSC discussion meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BEBDD7BF-6768-4954-A3E7-E4C07453DFCA</gtr:id><gtr:impact>RSC 2 day discussion meeting for ca. 120 leading academics, policymakers and other stakeholders

RSC published summary booklet</gtr:impact><gtr:outcomeId>BFEEE886524</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk , LMB Alumni symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9116153F-4426-44A5-A9B4-6CFA0508FB80</gtr:id><gtr:impact>talk sparked question and discussions afterwards

increased interest in my research</gtr:impact><gtr:outcomeId>5460ab160e81c4.57314271</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www2.mrc-lmb.cam.ac.uk/alumnisymposium/programme.php</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview (Deutschlandfunk 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>56EED8E7-B9EE-43D3-A9A4-6CC52EB494FD</gtr:id><gtr:impact>radio interview</gtr:impact><gtr:outcomeId>H2fV7zc3PvM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dradio.de/dlf/sendungen/forschak/2171572/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New polymerases for old DNA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>02936602-C12C-4469-B340-9A50E7A611F7</gtr:id><gtr:impact>talk on &amp;quot;Second Nature&amp;quot;, Nature publishings virtual web conference site in Second Life

follow up questions from public by e-mail</gtr:impact><gtr:outcomeId>31633D2DD98</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Discovery program, World service</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F3031A23-6F0F-4040-947D-79AD47506E9B</gtr:id><gtr:impact>Radio interview

NA</gtr:impact><gtr:outcomeId>qaWZGJqxzic</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>334000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EuroSynBio - SYNAPTA</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/I004793/1</gtr:fundingRef><gtr:id>A2FA2D72-0E8A-4858-AA3D-72F05C31E418</gtr:id><gtr:outcomeId>N5w5x3R1NUt0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>287638</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>14-ERASynBio INTENSIFYBBSRC</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M005623/1</gtr:fundingRef><gtr:id>F16FD981-A5BF-49CE-B396-8930E9AB5B58</gtr:id><gtr:outcomeId>545d07f8a11421.55920209</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>243000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Simons Collaboration on the Origins of Life Postdoctoral Fellowship</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Simons Foundation</gtr:fundingOrg><gtr:fundingRef>293387</gtr:fundingRef><gtr:id>0595E9A9-1D6B-44A8-8774-45F099CFF499</gtr:id><gtr:outcomeId>iEKk6h26f3y</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>263000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LMB / AZ / Medi / Research Agreement</gtr:description><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:fundingRef>BSF24</gtr:fundingRef><gtr:id>B458177D-3643-446B-8B98-EB7C3234DA4C</gtr:id><gtr:outcomeId>58b6e903d1f970.40117929</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93780</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HFSP Fellowship</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Human Frontier Science Program (HFSP)</gtr:fundingOrg><gtr:fundingRef>LT000045/2012</gtr:fundingRef><gtr:id>303F0052-6861-4E49-82CD-1F4E9156AC25</gtr:id><gtr:outcomeId>grn5syX5568</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>205948</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LMB / AZ / Medi / Research Agreement</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>BDF52CCB-DB7D-4362-9627-58AB9E16F725</gtr:id><gtr:outcomeId>58b6e7fdc23569.05193449</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>215642</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LMB / AZ / Medi / Research Agreement</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>CAA8875C-09F0-4CB1-ACA4-FB78502ADFB4</gtr:id><gtr:outcomeId>58b6e50c30a337.29185134</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>44700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Gates Cambridge Scholarship</gtr:department><gtr:description>US Gates - Duffy</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>07504A44-3399-449A-954B-8A6D170DE003</gtr:id><gtr:outcomeId>58b6ebf9273d30.72606158</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FEBS Fellowship</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Federation of European Biochemical Societies (FEBS)</gtr:fundingOrg><gtr:id>BAD43E4E-24FD-467F-8BEA-73BFE59610C2</gtr:id><gtr:outcomeId>YCRsT5JXnnk</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DFG Fellowship (Baar)</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:id>0A60D8BF-4900-4417-B3E1-696DF640F042</gtr:id><gtr:outcomeId>Vuph1bhUHL80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NSERC Canada fellowship</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Natural Sciences and Engineering Research Council of Canada (NSERC)</gtr:fundingOrg><gtr:id>F43E35B6-D5C2-4806-8AB3-263679197C76</gtr:id><gtr:outcomeId>6848F9DE3640</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250283</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERASynBio2 - Orthogonal biosystems based on phosphonate XNAs</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>UCL Ref 168510 BB/N01023X/1</gtr:fundingRef><gtr:id>E7BE020E-6A11-4381-9BC2-9EFC84A8800B</gtr:id><gtr:outcomeId>58b6e8a6b64466.95114843</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Junior Research Fellowship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>D90F47EA-0000-450A-9FD6-DB94D8D7E929</gtr:id><gtr:outcomeId>bA5Jb64mKz3</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37805</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DFG, Fellowship</gtr:description><gtr:end>2006-01-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:id>E3387CE7-7E50-40B4-AA82-7A2AFAED3C5B</gtr:id><gtr:outcomeId>95915BBD4E80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2004-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>403381</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FP6 NEST Pathfinder</gtr:description><gtr:end>2009-07-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>26DBC5A7-A2A9-48FB-995E-082EEA29C771</gtr:id><gtr:outcomeId>291B33148580</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1360</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Internship</gtr:description><gtr:end>2006-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>32EB908C-1A28-4B3B-B92E-3EB046427BBF</gtr:id><gtr:outcomeId>2F27B823C630</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT DGF Project Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:fundingRef>A853-0137</gtr:fundingRef><gtr:id>9D3DAD98-DAE8-4816-BBCD-7049D8CBF60B</gtr:id><gtr:outcomeId>DbjiCvkaaiP0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>directed evolution method based on the novel principle of compartmentalized self-replication</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>C888DEC6-A6A0-47AE-8C4E-5B08C542B9F5</gtr:id><gtr:impact>Method to select for proteins with altered characteristics. The protein of interest is randomly mutated and variants of it undergo selection based on presence or absence of nucleic acid polymerase activity.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>6B1315692FD</gtr:outcomeId><gtr:patentId>WO00222869A2</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Directed Evolution Method</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>novel inert oxidant-free emulsion formulation</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>63392C7D-7CB9-4562-9BC9-59F02A6F84B0</gtr:id><gtr:impact>Invention describes improved chemical composition of two phase emulsions. Such emulsions are of use for large scale screening</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>B2E1C4D5FFD</gtr:outcomeId><gtr:patentId>US2008187968</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Emulsion Compositions</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A novel method for the selection of nucleic acid processing and other enzymes and in particular polymerases</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>245F6E2D-D055-4514-90DE-F9F6853AA134</gtr:id><gtr:impact>A novel method for the selection of nucleic acid processing and other enzymes based on the compartmentalized self-tagging technique</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>0B3EADB9CE9</gtr:outcomeId><gtr:patentId>WO2005045072</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>CST Emulsions</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>polymerases with a resitance to common environmental inhibitors e.g. humic acid</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>AB4BFEA8-BAB5-49BF-8A25-86085B613E0E</gtr:id><gtr:impact>improved diagnostic &amp;amp; forensic PCR assays, ancient DNA research</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>DEEE501471E</gtr:outcomeId><gtr:patentId>US2009305345</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Hu1 polymerase</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A polymerase for the high-density incorporation of fluorescent-dye labeled nucleotides into DNA</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>27DBE0C5-EA55-457D-9BF1-CF21FF30DE38</gtr:id><gtr:impact>improved microarray protocols, novel diagnostics</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>2181DA380F2</gtr:outcomeId><gtr:patentId>US2010035767</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>E10 polymerase</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>An artificial genetic system based on polymerase engineering enabling the discovery of novel biopolymer therapeutics</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>453F16B4-D317-4B99-B78E-2F9570AD5343</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>G5KvieXSR81</gtr:outcomeId><gtr:patentId>PCT/GB2011/000583</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Artificial genetic systems</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>polymerase for the synthesis of synthetic genetic polymers based on arabino-nucleotides</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>9A729C12-5C0F-4C2D-B156-86F845B18979</gtr:id><gtr:impact>none</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>J3KfmMsCBjU</gtr:outcomeId><gtr:patentId>PCT/GB2013/050991</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Arabino-DNA polymerase</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>improved methodology for CST emulsions, filed as a continuation in part</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>5D689B13-EF10-49C1-99AB-D0379C49D15E</gtr:id><gtr:impact>Significant improvement on CST (compartmentalised self tagging) method which is already patented and relates to screening of polymerases with specific properties. The method allows for selection of only true positives which was frequently not the case with the original CST.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>1651AC09CC8</gtr:outcomeId><gtr:patentId>US20100184071</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>CST2.0</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>polymerases with increased ability for mismatch extension, enhanced processivity and expanded substrate spectrum</gtr:description><gtr:grantRef>MC_U105178804</gtr:grantRef><gtr:id>B029BB93-BBB4-47C9-84F7-71C763790590</gtr:id><gtr:impact>Method for the generation of DNA polymerases which exhibit relaxed substrate specificity</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>10C11EE21DE</gtr:outcomeId><gtr:patentId>AU2010200031</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>M4 Emulsions</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal Society Policy seminar on &amp;quot;Synthetic Biology&amp;quot;</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6FBFAFC6-04E8-46B5-ACC3-A66FF50CE26B</gtr:id><gtr:outcomeId>5F9C9AFBE5A</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal Society of Chemistry Replicating and Learning from Nature Exploration Workshop</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AE36FCAD-2223-4A91-88FA-09416C66FC8A</gtr:id><gtr:outcomeId>58226CED959</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>polymerases with expanded substrate spectrum</gtr:description><gtr:id>61371B7D-D483-4A45-B14E-A3A3359D6260</gtr:id><gtr:impact>licensing deals with New England Biolabs, Human Genetic Signatures</gtr:impact><gtr:outcomeId>6F4860F8782</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CSR</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>novel polymerases capable of utilizing entirely unnatural orthogonal substrates</gtr:description><gtr:id>5E809A6F-C826-407E-B2DA-F260A7A292AE</gtr:id><gtr:impact>improved tools for e.g. generation of nucleic acid therapeutics</gtr:impact><gtr:outcomeId>2424E0CF8CD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CST</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>766C5376-2365-46DF-B01D-96128D57D44B</gtr:id><gtr:title>Directed evolution of artificial enzymes (XNAzymes) from diverse repertoires of synthetic genetic polymers.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634c4d2f0dcfa06b57dcd675a9bf88ae"><gtr:id>634c4d2f0dcfa06b57dcd675a9bf88ae</gtr:id><gtr:otherNames>Taylor AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>56e03f338bc384.57633877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66176A73-FE3D-4901-8037-D6F53F159CB8</gtr:id><gtr:title>Origins of life: The cooperative gene.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bae7cdae0dbce4ab028bc9eaf5e0e79"><gtr:id>0bae7cdae0dbce4ab028bc9eaf5e0e79</gtr:id><gtr:otherNames>Attwater J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_14659_29_23075847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>265C5FC7-5BED-4D81-82FC-BD632B9F591D</gtr:id><gtr:title>Polymerase engineering: towards the encoded synthesis of unnatural biopolymers.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/116d74af444da18129b606fedd316811"><gtr:id>116d74af444da18129b606fedd316811</gtr:id><gtr:otherNames>Loakes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>E931853188D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F7420BB-DA23-4B85-912A-517C6049A68E</gtr:id><gtr:title>Non-canonical 3'-5' extension of RNA with prebiotically plausible ribonucleoside 2',3'-cyclic phosphates.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9740da461edc873a92bedba56d4f7db3"><gtr:id>9740da461edc873a92bedba56d4f7db3</gtr:id><gtr:otherNames>Mutschler H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>545d04d722f235.97033765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3137305-3418-49BC-8BD3-C78F8AA1463E</gtr:id><gtr:title>Binding of MutS protein to oligonucleotides containing a methylated or an ethylated guanine residue, and correlation with mutation frequency.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43ad496092e8a3222aab54f0d291307e"><gtr:id>43ad496092e8a3222aab54f0d291307e</gtr:id><gtr:otherNames>Taira K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>6BB5412C4E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23860D42-2061-48B6-94E4-0C3A9B174889</gtr:id><gtr:title>Towards XNA nanotechnology: new materials from synthetic genetic polymers.</gtr:title><gtr:parentPublicationTitle>Trends in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97265c31794d4e83223abb58cef55e97"><gtr:id>97265c31794d4e83223abb58cef55e97</gtr:id><gtr:otherNames>Pinheiro VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0167-7799</gtr:issn><gtr:outcomeId>545d04d779b441.01979322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5C54F96-08B0-44D4-89D3-3B8EDDCB9168</gtr:id><gtr:title>Molecular breeding of polymerases for amplification of ancient DNA.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8af32db961c3a0678f975626efa1649c"><gtr:id>8af32db961c3a0678f975626efa1649c</gtr:id><gtr:otherNames>d'Abbadie M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>34054243EEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>613F4C97-5A18-4075-8565-D069786407A8</gtr:id><gtr:title>Effect of a Hydrogen Bonding Carboxamide Group on Universal Bases</gtr:title><gtr:parentPublicationTitle>Collection of Czechoslovak Chemical Communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79b9e9b79ffbe11d0a6baa406193e1b5"><gtr:id>79b9e9b79ffbe11d0a6baa406193e1b5</gtr:id><gtr:otherNames>Too K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>3A8CCCC7BB9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE32F1C6-18F9-4FFD-ADE2-37629DD493CB</gtr:id><gtr:title>Nucleic acids: function and potential for abiogenesis.</gtr:title><gtr:parentPublicationTitle>Quarterly reviews of biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4313bd465b4b8ce09a7f64613afcd0f"><gtr:id>b4313bd465b4b8ce09a7f64613afcd0f</gtr:id><gtr:otherNames>Wachowius F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0033-5835</gtr:issn><gtr:outcomeId>5a9c2d1de67919.72742212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>207E1B8A-389A-410E-81C8-37EAF8754B74</gtr:id><gtr:title>Exploring the Chemistry of Genetic Information Storage and Propagation through Polymerase Engineering.</gtr:title><gtr:parentPublicationTitle>Accounts of chemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a07f08a3a1ce572eb94db142d7525e80"><gtr:id>a07f08a3a1ce572eb94db142d7525e80</gtr:id><gtr:otherNames>Houlihan G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-4842</gtr:issn><gtr:outcomeId>5a2fd93b3ad319.74649007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD653F9F-9010-4D38-B59F-1F576C61BBE1</gtr:id><gtr:title>Influence of neighbouring base sequences on the mutagenesis induced by 7,8-dihydro-8-oxoguanine in yeast.</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d16bf75b99c9eec40ca88add6f4c80f"><gtr:id>4d16bf75b99c9eec40ca88add6f4c80f</gtr:id><gtr:otherNames>Yung CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>2DE0AD62BD8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8969394-C125-4B20-8289-4DBC216F23D3</gtr:id><gtr:title>Lethal mutagenesis of picornaviruses with N-6-modified purine nucleoside analogues.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22dda7a100bf6658aa88d0b35241c5a0"><gtr:id>22dda7a100bf6658aa88d0b35241c5a0</gtr:id><gtr:otherNames>Graci JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>6C0607C33E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>798327E4-17BA-4D91-B036-1C916E4201BB</gtr:id><gtr:title>Selection of 2'-deoxy-2'-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/946ad3f3fb696142053ab8b658b934df"><gtr:id>946ad3f3fb696142053ab8b658b934df</gtr:id><gtr:otherNames>Alves Ferreira-Bravo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56e03f335ddb37.36998778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68B426E1-36EA-4DE2-9BA4-46738A28B2F5</gtr:id><gtr:title>Catalysts from synthetic genetic polymers.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634c4d2f0dcfa06b57dcd675a9bf88ae"><gtr:id>634c4d2f0dcfa06b57dcd675a9bf88ae</gtr:id><gtr:otherNames>Taylor AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5675dd7337659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E067D63-1000-4E46-948D-A80BB64C104F</gtr:id><gtr:title>A short adaptive path from DNA to RNA polymerases.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3e890e72fe14cf670c6e6480771be11"><gtr:id>f3e890e72fe14cf670c6e6480771be11</gtr:id><gtr:otherNames>Cozens C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14659_29_22566643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA9C789E-DED5-4214-B84A-071CEFE1D5D5</gtr:id><gtr:title>Reversible fluorescence photoswitching in DNA.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605443418fad16418b9c37d92dc83b00"><gtr:id>605443418fad16418b9c37d92dc83b00</gtr:id><gtr:otherNames>Smith DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>pm_14659_29_22861666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99CE87F5-632E-46CB-8350-44AB7527AE0E</gtr:id><gtr:title>Translesion synthesis across the (6-4) photoproduct and its Dewar valence isomer by the Y-family and engineered DNA polymerases.</gtr:title><gtr:parentPublicationTitle>Nucleic acids symposium series (2004)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a584b4403b7c1dd7d4a3d0a1bbfb31cd"><gtr:id>a584b4403b7c1dd7d4a3d0a1bbfb31cd</gtr:id><gtr:otherNames>Yamamoto J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0261-3166</gtr:issn><gtr:outcomeId>F7B411C440B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A1056E-5A74-4DB5-ABAD-D9ED8E9C794C</gtr:id><gtr:title>Evolving a polymerase for hydrophobic base analogues.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/116d74af444da18129b606fedd316811"><gtr:id>116d74af444da18129b606fedd316811</gtr:id><gtr:otherNames>Loakes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>674F27A8161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9743527C-EB15-4640-AA00-6DB0EEAF09A0</gtr:id><gtr:title>Ice as a protocellular medium for RNA replication.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bae7cdae0dbce4ab028bc9eaf5e0e79"><gtr:id>0bae7cdae0dbce4ab028bc9eaf5e0e79</gtr:id><gtr:otherNames>Attwater J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>qUtrxky3woY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7AE905-04B6-4C84-9CFB-6282CCF68ED6</gtr:id><gtr:title>Enzymatic Synthesis of Nucleic Acids with Defined Regioisomeric 2'-5' Linkages.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3e890e72fe14cf670c6e6480771be11"><gtr:id>f3e890e72fe14cf670c6e6480771be11</gtr:id><gtr:otherNames>Cozens C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56e03f333b0ff9.55551262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7399189F-2984-4B46-9823-2E9BED2EDDBC</gtr:id><gtr:title>CyDNA: synthesis and replication of highly Cy-dye substituted DNA by an evolved polymerase.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aa1d03ad868745fbee35d22cfa0ad34"><gtr:id>1aa1d03ad868745fbee35d22cfa0ad34</gtr:id><gtr:otherNames>Ramsay N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>G6nyGJs5egz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C389BAE0-13D3-4A08-B8EF-BB4C87A14C73</gtr:id><gtr:title>Freeze-thaw cycles as drivers of complex ribozyme assembly.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9740da461edc873a92bedba56d4f7db3"><gtr:id>9740da461edc873a92bedba56d4f7db3</gtr:id><gtr:otherNames>Mutschler H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn><gtr:outcomeId>56dffe33197665.73441456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5681AB5-F830-470B-A4D3-EA483AEE118A</gtr:id><gtr:title>Simple peptides derived from the ribosomal core potentiate RNA polymerase ribozyme function.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/302a1508c820c18ea618d927f4e155d1"><gtr:id>302a1508c820c18ea618d927f4e155d1</gtr:id><gtr:otherNames>Tagami S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn><gtr:outcomeId>5a31e1614db2d6.39269566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>657957BA-36CF-4627-B2E9-DEEC226BCE8F</gtr:id><gtr:title>Synthetic genetic polymers capable of heredity and evolution.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97265c31794d4e83223abb58cef55e97"><gtr:id>97265c31794d4e83223abb58cef55e97</gtr:id><gtr:otherNames>Pinheiro VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_14659_29_22517858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40F14696-B905-471F-B595-5AD10E4BE84F</gtr:id><gtr:title>Ribozyme-catalyzed transcription of an active ribozyme.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7eb5e47d00efc60351fc3455988725de"><gtr:id>7eb5e47d00efc60351fc3455988725de</gtr:id><gtr:otherNames>Wochner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>JvN4DYi1FXt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C951D31B-E213-4FD0-AD28-F8CBE6F1EB3E</gtr:id><gtr:title>Anti-malarial activity of N6-modified purine analogues.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79b9e9b79ffbe11d0a6baa406193e1b5"><gtr:id>79b9e9b79ffbe11d0a6baa406193e1b5</gtr:id><gtr:otherNames>Too K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>B5B3BD0EE7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3911F29C-ED12-4C31-935A-8B20CEDBBCAA</gtr:id><gtr:title>Chemical fidelity of an RNA polymerase ribozyme</gtr:title><gtr:parentPublicationTitle>Chemical Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bae7cdae0dbce4ab028bc9eaf5e0e79"><gtr:id>0bae7cdae0dbce4ab028bc9eaf5e0e79</gtr:id><gtr:otherNames>Attwater J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_14659_c3sc50574j</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>525D79EA-C753-43DA-B381-A066243170F2</gtr:id><gtr:title>Template properties of mutagenic cytosine analogues in reverse transcription.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03d4fdb4a700578ff3369686ce0847aa"><gtr:id>03d4fdb4a700578ff3369686ce0847aa</gtr:id><gtr:otherNames>Suzuki T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>24D19AF0A97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F023802-18D0-46AE-8F66-FFCB6C196643</gtr:id><gtr:title>Protein Engineering Handbook: Volume 3</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78020476d996fcf60cbd2be95fbfd835"><gtr:id>78020476d996fcf60cbd2be95fbfd835</gtr:id><gtr:otherNames>Pinheiro, V.B.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-3-527-33123-9</gtr:isbn><gtr:outcomeId>kA4nJKdKBv1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F65FC74-70E1-4FA6-9184-BB2CE9A37822</gtr:id><gtr:title>Molecular breeding of polymerases for resistance to environmental inhibitors.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfca1f412bbac6bb6f40239b1fe7d699"><gtr:id>bfca1f412bbac6bb6f40239b1fe7d699</gtr:id><gtr:otherNames>Baar C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>Mgfd35WSiSn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48606129-7347-47AD-846C-F35F24DA0A04</gtr:id><gtr:title>Isoguanine and 5-methyl-isocytosine bases, in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f01a71385d3027d39d97a774ae11632d"><gtr:id>f01a71385d3027d39d97a774ae11632d</gtr:id><gtr:otherNames>Bande O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>56dffe32ab6522.98695592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08785AAB-DE4B-412B-88BE-54A0E5E47C87</gtr:id><gtr:title>Nanostructures from Synthetic Genetic Polymers.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634c4d2f0dcfa06b57dcd675a9bf88ae"><gtr:id>634c4d2f0dcfa06b57dcd675a9bf88ae</gtr:id><gtr:otherNames>Taylor AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>58b6e2ef560850.83079836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B965263C-5801-4FEA-A904-0F9B71E0FB92</gtr:id><gtr:title>Towards applications of synthetic genetic polymers in diagnosis and therapy.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634c4d2f0dcfa06b57dcd675a9bf88ae"><gtr:id>634c4d2f0dcfa06b57dcd675a9bf88ae</gtr:id><gtr:otherNames>Taylor AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn><gtr:outcomeId>545d04d7ca9767.91752594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A0CEC0-AAEC-4BEA-A417-CDB24C0475A0</gtr:id><gtr:title>Structures of an apo and a binary complex of an evolved archeal B family DNA polymerase capable of synthesising highly cy-dye labelled DNA.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97e064d7372408e2d4250ed78e3d5fc7"><gtr:id>97e064d7372408e2d4250ed78e3d5fc7</gtr:id><gtr:otherNames>Wynne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545d0424bd6634.73474940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F0D3327-15EC-402A-AC27-5A4C7181722C</gtr:id><gtr:title>The XNA world: progress towards replication and evolution of synthetic genetic polymers.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97265c31794d4e83223abb58cef55e97"><gtr:id>97265c31794d4e83223abb58cef55e97</gtr:id><gtr:otherNames>Pinheiro VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn><gtr:outcomeId>pm_14659_29_22704981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAF823C3-1EBC-4EC4-92A6-E3FB732A6A52</gtr:id><gtr:title>Directed evolution of DNA polymerase, RNA polymerase and reverse transcriptase activity in a single polypeptide.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce340ad978cb40bc341e4b1c7549f63"><gtr:id>6ce340ad978cb40bc341e4b1c7549f63</gtr:id><gtr:otherNames>Ong JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>1F26A45C6F3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D12DFC8-A660-44FE-8A89-8EB455183389</gtr:id><gtr:title>Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA x anti-CD3 diabodies from lentivirally transduced human lymphocytes.</gtr:title><gtr:parentPublicationTitle>Cancer gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8f5dcd48e4913d5cb2c78507f07deb0"><gtr:id>c8f5dcd48e4913d5cb2c78507f07deb0</gtr:id><gtr:otherNames>Compte M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0929-1903</gtr:issn><gtr:outcomeId>0882131F8F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10F3E8E7-7B50-4EA1-9DA8-53294824F035</gtr:id><gtr:title>The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7d2f9e5fce732f60050759752766e52"><gtr:id>b7d2f9e5fce732f60050759752766e52</gtr:id><gtr:otherNames>Stadler LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545d04d754d259.68854586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0AA567B-2779-4F82-8D73-884E59DFF741</gtr:id><gtr:title>Darwinian chemistry: towards the synthesis of a simple cell.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/116d74af444da18129b606fedd316811"><gtr:id>116d74af444da18129b606fedd316811</gtr:id><gtr:otherNames>Loakes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>F8993586DA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3875407D-16B2-4C0B-9908-FE7E498F583C</gtr:id><gtr:title>In vitro anti-malarial activity of N6-modified purine analogs.</gtr:title><gtr:parentPublicationTitle>Nucleosides, nucleotides &amp; nucleic acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79b9e9b79ffbe11d0a6baa406193e1b5"><gtr:id>79b9e9b79ffbe11d0a6baa406193e1b5</gtr:id><gtr:otherNames>Too K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1525-7770</gtr:issn><gtr:outcomeId>BD366CE667A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F5AD3CC-2D05-4EFC-87B2-94427DD8FB2E</gtr:id><gtr:title>Engineering and application of polymerases for synthetic genetics.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a07f08a3a1ce572eb94db142d7525e80"><gtr:id>a07f08a3a1ce572eb94db142d7525e80</gtr:id><gtr:otherNames>Houlihan G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>5a2fd8f0b1eda5.42946851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6670BF91-4C01-4CA5-8C63-CDF1086ECF21</gtr:id><gtr:title>A polymerase engineered for bisulfite sequencing.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebb4c1498985d7449c7d7f797796d5da"><gtr:id>ebb4c1498985d7449c7d7f797796d5da</gtr:id><gtr:otherNames>Millar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56e03f32ec9e40.85933002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCB4680D-F27C-4673-A1D9-615F4A37D4E3</gtr:id><gtr:title>Compartmentalized self-replication: a novel method for the directed evolution of polymerases and other enzymes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3c7298acbfef54d1a7e0400422963d0"><gtr:id>d3c7298acbfef54d1a7e0400422963d0</gtr:id><gtr:otherNames>Ghadessy FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>244AC9290A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17ABB87A-4266-48C3-8B3A-45E3F05390B1</gtr:id><gtr:title>Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22dda7a100bf6658aa88d0b35241c5a0"><gtr:id>22dda7a100bf6658aa88d0b35241c5a0</gtr:id><gtr:otherNames>Graci JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>E5808CD86FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85F10A93-F244-4910-B464-889DE34B261E</gtr:id><gtr:title>Subunit disassembly and inhibition of TNFa by a semi-synthetic bicyclic peptide.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05592184934558eefb961d3ac4c3a79f"><gtr:id>05592184934558eefb961d3ac4c3a79f</gtr:id><gtr:otherNames>Luzi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>56dffe32d6fff9.30328031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DC95971-8CCC-4347-A094-F78BBC56E5EC</gtr:id><gtr:title>Solution structure and dynamics of DNA duplexes containing the universal base analogues 5-nitroindole and 5-nitroindole 3-carboxamide.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac868506b3b95230d51270d7d7b1dfed"><gtr:id>ac868506b3b95230d51270d7d7b1dfed</gtr:id><gtr:otherNames>Gallego J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>F8C282C2674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE0437E8-2613-453B-A1A8-290B28DFB1C3</gtr:id><gtr:title>Chemical biotechnology--a marriage of convenience and necessity.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b9f8cf0c55c71672f594e39c7ef197"><gtr:id>97b9f8cf0c55c71672f594e39c7ef197</gtr:id><gtr:otherNames>Jaeger KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>Rj5AiSSj8dp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>835F97DE-6BB9-428E-BB6A-4EB45273FAAB</gtr:id><gtr:title>In-ice evolution of RNA polymerase ribozyme activity.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bae7cdae0dbce4ab028bc9eaf5e0e79"><gtr:id>0bae7cdae0dbce4ab028bc9eaf5e0e79</gtr:id><gtr:otherNames>Attwater J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn><gtr:outcomeId>doi_14659_nchem_1781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F6B444F-CBB0-4068-8DBC-2281B4ABC62D</gtr:id><gtr:title>Systems Biology and Synthetic Biology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d8dc57afcc02600707257783872e92c"><gtr:id>1d8dc57afcc02600707257783872e92c</gtr:id><gtr:otherNames>Holliger P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>9780471767787</gtr:isbn><gtr:outcomeId>tDLWSj7EYyK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E99519C4-C309-44FC-B13F-5CCAC583151E</gtr:id><gtr:title>A synthetic approach to abiogenesis.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bae7cdae0dbce4ab028bc9eaf5e0e79"><gtr:id>0bae7cdae0dbce4ab028bc9eaf5e0e79</gtr:id><gtr:otherNames>Attwater J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>545d04d7a1e043.31375885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC7C1B19-A77F-4EFF-82D8-0951192FB3C3</gtr:id><gtr:title>Compartmentalized Self-Tagging for In Vitro-Directed Evolution of XNA Polymerases.</gtr:title><gtr:parentPublicationTitle>Current protocols in nucleic acid chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97265c31794d4e83223abb58cef55e97"><gtr:id>97265c31794d4e83223abb58cef55e97</gtr:id><gtr:otherNames>Pinheiro VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1934-9270</gtr:issn><gtr:outcomeId>5460dd905ca605.04691281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93FC1A3E-9DF8-46E2-BB3B-6D1209D9A5A7</gtr:id><gtr:title>Synthetic polymers and their potential as genetic materials.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97265c31794d4e83223abb58cef55e97"><gtr:id>97265c31794d4e83223abb58cef55e97</gtr:id><gtr:otherNames>Pinheiro VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_14659_29_23281109</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105178804</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>